GENE ONLINE|News &
Opinion
Blog

.

Зеркало официального сайта всегда доступно для входа на Мостбет, даже при ограничениях. Скачать Mostbet – это шаг к удобству и азартным развлечениям.

Если вы ищете место для увлекательных ставок, обратите внимание на Joycasino, где лучшие предложения для игроков ждут вас.
2021-04-08| Asia-PacificCOVID-19

Thailand Greenlights $78 Million Worth Projects in Biotech Sector for Post COVID-19 Recovery

by Tyler Chen
Share To

(Photo Courtesy: The Thailand Board of Investment)

Thailand has met a surge of medical project applications during the COVID-19 pandemic. On April 5th, the Thailand Board of Investment (BOI) approved four advanced biotech projects with a combined worth $78 million (2.4 billion baht).

The 4 Biotech Projects

To start with, Thailand approved Thai Kyowa Biotechnologies, a subsidiary of Japan’s Kirin Holdings and the manufacturer of amino acids, to develop Human Milk Oligosaccharide (HMO). It is a prebiotic used in milk powder that can build immunity in the human body. Secondly, Genepeutic Bio was authorized to develop CAR T Cell advanced therapy medicinal products (ATMP) for patients with Acute Lymphoblastic Leukemia (ALL).

Other than that, food and beverage manufacturer Fruita Biomed was approved to produce PHA (Polyhydroxyalkanoate) bioplastic and PHA bioplastic compounds from organic waste to create packaging for food and medical supplies. Lastly, Thai startup from CU Innovation Hub Baiya Phytopharm is authorized to develop plant-based vaccines and therapeutic proteins, using molecular pharming technology.

“These new and exciting projects reflect investors’ continued interest in Thailand biotech capability,” Secretary General of the BOI Ms. Duangjai Asawachintachit said “adding to our strong agricultural base and biodiversity, Thailand has now also a very strong pool of researchers that allow us to move into advanced technology.”

Thailand’s Plan to Invest on BCG Sectors

These approvals are an outcome of Thailand’s plan to revive the economy post COVID-19. The government has prioritized developing the Bio, Circular and Green economy (BCG) model, which consists of agriculture and food; bioenergy, biomaterials and biochemicals; medical and wellness; and tourism and the creative economy. As stated in BOI’s data, BCG sectors’ economic value was around $113 billion and projected to reach $147 billion by 2025 with a whopping 30% growth.

Further, biotechnology is one of the 10 targeted industries under the Thailand 4.0 growth model and has played a strategic role in strengthening Thailand’s competitiveness in the global market.

On top of that, the pandemic has enriched the development and investment in the sectors. In the first half of 2020, Thai and international investors infused $400 million (12.69 billion baht) investment with 50 projects in Thailand, demonstrating a 174% rise in project number and a 123% increase in investment value compared to the same period last year. What’s more, most projects in the investments were medical devices manufacturing related.

Ms. Duangjai Asawachintachit, Secretary General of the BOI said, “we have approved more than 80 percent of the projects in order to respond to the situation, while paving the way for Thailand’s longer-term development as a manufacturing hub for medical devices and supplies.”

Related Article: Eisai Enters Vietnam With a Subsidiary

©www.geneonline.com All rights reserved. Collaborate with us: [email protected]
Related Post
Thailand’s Bold Leap Into the Future to Modernize Healthcare with Digital Transformation and Advanced Technology
2024-12-31
How TCELS is Moving Thailand’s Biotech Industries From Local to Global
2024-10-04
Thai Biotech Industry’s Promising Potential: Taiwan Works Toward Strengthening APAC Ties at Bio Asia Pacific—Collaboration is Key
2024-09-24
LATEST
Novo Nordisk Bets Big on CagriSema With A Heavyweight Move Planned for 2026
2025-02-07
Major Win – FDA Grants Fast Track Designation to Adicet Bio’s ADI-001 for Lupus Disease
2025-02-07
First-of-its-Kind Diagnostic Aid Uses a Single Hair Strand to Detect Autism Risk in Babies
2025-02-06
Teladoc Dials Up Virtual Care with $70 Million Acquisition of Catapult
2025-02-06
Silicon Valley in the Crosshairs as EU Readies to Strike U.S. Big Tech
2025-02-06
Johnson & Johnson Under Fire Again as Legal Action Over Alleged Talc-Cancer Link Moves to the UK
2025-02-05
MediBuddy Partners with Japan’s ELECOM to Launch Smart Health IoT Devices in India
2025-02-05
EVENT
2025-02-05
Precision Medicine World Conference 2025
Santa Clara, California
2025-02-19
Healthcare Conference Taipei 2025
Taipei, Taiwan
2025-03-17
BIO-Europe Spring 2025
Milan, Italy
2025-04-21
World Vaccine Congress 2025
Washington, U.S.A
2025-04-25
AACR Annual Meeting 2025
Chicago, U.S.A
Scroll to Top